Multilevel Stressors and Systemic and Tumor Immunity in Black and White Women With Breast Cancer
Alexandra R. Harris(University of Virginia), Stefan Ambs(University of Maryland, Baltimore), William Wooten(University of Maryland, Baltimore), Margaret S. Pichardo(Hospital of the University of Pennsylvania), Brittany D. Jenkins(Bloomberg (United States)), Jamirra Franklin(National Institutes of Health), Harry G. Yfantis(Veterans Health Administration), Tanya Agurs‐Collins(National Cancer Institute), Catherine M. Pichardo(National Institutes of Health), Gatikrushna Panigrahi(Atrium Health Wake Forest Baptist), Huaitian Liu(Center for Cancer Research), Wayne R. Lawrence(Albany State University), Tiffany H. Dorsey(Center for Cancer Research), Olga B. Ioffe(University of Maryland, Baltimore)
Cited by 9
Related Papers
The Lower Anogenital Squamous Terminology Standardization Project for HPV-Associated Lesions: Background and Consensus Recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology
|Archives of Pathology & Laboratory Medicine|2012|999
Genomic Profiling of MicroRNA and Messenger RNA Reveals Deregulated MicroRNA Expression in Prostate Cancer
|Cancer Research|2008|708
Tumor Immunobiological Differences in Prostate Cancer between African-American and European-American Men
|Cancer Research|2008|522
MYC-driven accumulation of 2-hydroxyglutarate is associated with breast cancer prognosis
|Journal of Clinical Investigation|2013|469
Increased NOS2 predicts poor survival in estrogen receptor–negative breast cancer patients
|Journal of Clinical Investigation|2010|250